DPP4 and type 2 diabetes mellitus: Third, we were unable to control for the effect of other anti-diabetic medications, except DPP-4 inhibitors, on DPP-4 or NPY family peptides expression in the small bowel muscular tissues, because we could not stop T2DM treatment in our population.